OpenAlex
PricingAboutJobs
Log inGet started
Work

The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity

HTML

Year: 2019
Type: review
Source: Expert Opinion on Therapeutic Targets
DOI: 10.1080/14728222.2019.1667977
Authors: Anne Bärenwaldt, Heinz Läubli
Institution: University Hospital of Basel
Language: English

Topic: Glycosylation and Glycoproteins Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: sialoglycans, sialic acid, Siglec receptors, immune checkpoint, cancer immunotherapy, natural killer cells, T cells, M2 macrophages, neuraminidase, CAR T-cell therapy, tumor microenvironment, myeloid differentiation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2974567434
FWCI: 0.96
Cites: 215
Cited by: 95
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security